News Roundup: February 27 to March 3
Your weekly roundup of the latest news from Drug Topics®.
Eli Lilly Slashing Insulin Prices, Capping Monthly Out of Pocket Costs For Many
The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.
FDA Accepts Verrica's Resumbitted NDA for VP-102
VP-102 hopes to treat molluscum contagiosum, pending approval from FDA
CMS Not Willing To Expand Alzheimer's Drug Coverage
CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.
FDA Accepts Supplemental BLA For Nivolumab For Melanoma
The PDFUA date for the drug is October 13, 2023.
How a Bill Becomes a Law: Pharmacy Legislation to Watch
Recent Videos
Related Content
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Podcast
Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
